See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

FDA clears Starlight Therapeutics' IND for Phase Ib/IIa glioblastoma trial

Summary by Clinical Trials Arena
The US FDA has cleared Starlight Therapeutics' IND for a Phase Ib/IIa trial assessing the combination of STAR-001.The post FDA clears Starlight Therapeutics’ IND for Phase Ib/IIa glioblastoma trial appeared first on Clinical Trials Arena.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

Clinical Trials ArenaClinical Trials Arena

FDA clears Starlight Therapeutics' IND for Phase Ib/IIa glioblastoma trial

The US FDA has cleared Starlight Therapeutics' IND for a Phase Ib/IIa trial assessing the combination of STAR-001.The post FDA clears Starlight Therapeutics’ IND for Phase Ib/IIa glioblastoma trial appeared first on Clinical Trials Arena.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Clinical Trials Arena broke the news in on Thursday, August 7, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

United States icon

United States

News
For You
SearchBlindspotLocal